Featured,Trends & Articles Oregon Adopts First Set of Therapeutic Psilocybin Measures By Dennis Mutua May 23, 2022 A few days ago, the Oregon Health Authority released a set of rules governing products testing and training programs for Oregon’s therapeutic psilocybin program which is slated to start next year. Back in February, the Oregon...
Spotlight Stock,Trends & Articles Dimension Health to Offer its First Psychedelic Retreat in July By Dennis Mutua May 20, 2022 Actively managed investment issuer proving investors with a diverse exposure to the psychedelic industry Origin Therapeutics Holding Inc. (CSE ORIG proposed) announced that one of its wholly owned subsidiaries Dimensions Health Ce...
Featured,Trends & Articles CSIRO Begins Research and Development Activities on Medicinal Psychedelics By Dennis Mutua May 18, 2022 Australia based Commonwealth Scientific and Industrial Research Organization (CSIRO) says that it has started working with local biotechnology and pharmaceutical companies to improve existing psychedelics products and develop new ...
Featured,Trends & Articles Ketamine Wellness Centers Inks Partnership Deal With the Veterans Administration in Arizona By Dennis Mutua May 16, 2022 Largest ketamine therapy provider in the United States offering infusions for depressions, chronic pains, anxiety among others Ketamine Wellness Centers (KWC) entered into a partnership deal with the Veterans Administration (VA) i...
Featured,Spotlight Stock,Trends & Articles Mindset Progresses its Lead Clinical Candidate MSP-1014 Towards Human Clinical Trials By Dennis Mutua May 13, 2022 Drug discovery and development company specializing on developing optimized and patentable next generation psychedelics medicines to treat neurological and psychiatrist disorders with unmet conditions Mindset Pharma Inc. (CSE: MSE...
Spotlight Stock,Trends & Articles Colorado Activists Collect Signatures to Put Psychedelics Reform on Ballot By Dennis Mutua May 12, 2022 Activists from Colorado championing for the change of legal status of psychedelics across the state have collected tens of thousands of signatures to put the psychedelic reform on the state’s November ballot. One wing of the cam...
Featured,Spotlight Stock,Trends & Articles Halucenex Granted Psilocybe Cubensis Import Permit by Health Canada By Dennis Mutua May 11, 2022 Life sciences development company focusing on performing psychedelic-assisted psychotherapy and clinical research Halucenex Life Sciences Inc. announced having secured a permit to import one kilogram of psilocybe cubensis to refin...
Featured,Trends & Articles New York Legislators Proposes Bills to Decriminalize Psychedelics By Dennis Mutua May 09, 2022 New York legislators have come up with several bills which are seeking to decriminalize use of psychedelic substances across the state. The bills were introduced late last week. Psychedelics is currently considered a Schedule I co...
